Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
03/2014
03/19/2014EP2707026A1 Production of dense bodies (db) from hcmv-infected cells
03/19/2014CN103641835A AZapyrenes For Electronic Applications
03/19/2014CN103641816A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103641786A Preparation method of erlotinib hydrochloride crystal form A
03/19/2014CN102755901B Preparation and application of composite solid acid catalyst used for condensation reaction
03/19/2014CN102675220B Etravirine preparing method and intermediate of etravirine
03/19/2014CN102659629B Compound and application thereof in preparing erlotinib
03/19/2014CN102131788B Compounds and compositions as protein kinase inhibitors
03/18/2014US8674106 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/18/2014US8674093 Process for the preparation of an orexin receptor antagonist
03/18/2014US8673929 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
03/18/2014US8673922 Azaindazole compounds
03/18/2014US8673884 Anti-influenza compounds
03/18/2014CA2743562C Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
03/18/2014CA2719538C Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
03/18/2014CA2619898C Diaminopyrimidines as p2x3 and p2x2/3 modulators
03/13/2014WO2014039714A2 Compounds and methods for kinase modulation, and indications therefor
03/13/2014WO2014037961A1 Crystalline erlotinib hydrochloride process
03/13/2014WO2014036766A1 Novel smectic phase a liquid crystal material
03/13/2014US20140073659 Treatment for vitiligo
03/13/2014US20140073651 Benzamide derivatives as p2x7 receptor antagonists
03/13/2014US20140073642 Quinazoline derivatives for the treatment of viral infections and further diseases
03/13/2014US20140073639 Inhibition of antimicrobial targets with reduced potential for resistance
03/13/2014US20140073632 Treating protein folding disorders with small molecule cftr correctors
03/13/2014US20140073620 Vegfr3 inhibitors
03/12/2014CN103635192A Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use
03/12/2014CN103626742A Bi-aryl meta-pyrimidine inhibitors of kinases
03/12/2014CN103626708A Novel sulfonylurea compound
03/12/2014CN102060875B Quinazoline derivative, and preparation method and application thereof
03/12/2014CN101720318B Quinazolin-oxime derivatives as Hsp90 inhibitors
03/12/2014CN101679191B Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/11/2014US8669361 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/11/2014US8669254 Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
03/11/2014CA2655801C Therapeutic or prophylactic agent for leukemia
03/06/2014WO2014036022A1 Quinazolinone compounds and derivatives thereof
03/06/2014WO2013190510A3 NOVEL 2,3-DIHYDRO-1H-IMIDAZO{1,2-a}PYRIMIDIN-5-ONE and this1,2,3,4-TETRAHYDROPYRIMIDO{1,2-a}PYRIMIDIN-6-ONE DERIVATIVES COMPRISING A SUBSTITUTED MORPHOLINE, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF
03/06/2014WO2012087888A3 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt
03/06/2014US20140066623 Ribosome Structure and Protein Synthesis Inhibitors
03/06/2014US20140066425 Androgen receptor antagonists and uses thereof
03/06/2014US20140066422 Phenoxy-substituted pyrimidines as opioid receptor modulators
03/06/2014US20140066419 Hydroxamic acid derivatives
03/06/2014US20140066407 Fungicide Active Substance Combinations
03/06/2014US20140066369 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
03/05/2014EP2702045A1 Novel process for the preparation of etravirine
03/05/2014EP2702044A2 Process for rilpivirine
03/05/2014EP2702043A1 Inhibitors of inducible form of 6-phosphofructose-2-kinase
03/05/2014EP2702033A1 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
03/05/2014CN103619823A Crystals of glycine derivative and pharmaceutical use thereof
03/05/2014CN103613550A Environment-friendly synthesis method for 4(3H)-quinazolinone
03/05/2014CN103613549A Afloqualone preparation method
03/05/2014CN102260217B 2-sulfo-quinazoline derivative and synthesis method
03/05/2014CN101701006B Phenethanolamine derivatives for treatment of respiratory diseases
03/05/2014CN101588716B Substance capable of inhibiting cytokinin signaling
03/04/2014US8664389 Process for the preparation of lapatinib and it's pharmaceutically acceptable salts
03/04/2014US8664388 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture
03/04/2014US8664387 Pyridoquinazolinone M1 receptor positive allosteric modulators
03/04/2014US8664234 Dihydrobenzoquinazolinone M1 receptor positive allosteric modulators
02/2014
02/27/2014WO2014031571A1 Treatment of viral infections
02/27/2014WO2014030743A1 Heterocycic compound
02/27/2014WO2014029007A1 Protein kinase inhibitors
02/27/2014WO2014011900A3 Inhibitors of the fibroblast growth factor receptor
02/27/2014WO2014001215A3 3-o-heteroaryl-ingenol
02/27/2014US20140057929 Besylate salt of a btk inhibitor
02/27/2014US20140057913 Aurora kinase inhibitors and methods of making and using thereof
02/27/2014US20140057912 Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
02/27/2014US20140057911 Novel 4,6-disubstituted aminopyrimidine derivatives having both aromatic and halogenic substituents
02/26/2014EP2699553A1 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
02/26/2014EP2699552A1 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
02/26/2014EP2699547A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators
02/26/2014CN103608336A 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof
02/26/2014CN103608335A Pyrimidine derivatives for the treatment of viral infections
02/26/2014CN103608326A Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
02/26/2014CN103607895A Cyclohexanone compounds and herbicides comprising same
02/26/2014CN103601688A Synthetic method of trimethoprim impurity
02/26/2014CN103601687A Preparation method of rosuvastatin sodium
02/26/2014CN103601686A Method for synthesizing fluorine-containing pyrimidine compounds by virtue of one-pot method
02/26/2014CN101671301B Heterocyclic substituent acardite derivate and application thereof
02/25/2014US8658793 Process for the preparation of pyrimidine derivatives
02/25/2014US8658791 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3-alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides
02/25/2014US8658790 Stereoselective synthesis of bicyclic heterocycles
02/25/2014US8658776 Synthesis of 2′,3′-dideoxynucleosides for automated DNA synthesis and pyrophosphorolysis activated polymerization
02/25/2014US8658657 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity
02/25/2014US8658656 Methods and compositions utilizing quinazolinones
02/25/2014US8658655 Inhibition of activated cdc42-associated kinase 1
02/25/2014US8658654 Receptor-type kinase modulators and methods of use
02/25/2014CA2636993C Pyrimidine derivatives used as pi-3 kinase inhibitors
02/22/2014CA2787472A1 Protein kinase inhibitors
02/20/2014WO2014028914A1 Deuterated icotinib derivatives
02/20/2014WO2014028669A1 Novel compounds for modulation of ror-gamma activity
02/20/2014WO2014026243A1 Vegfr3 inhibitors
02/20/2014WO2014026242A1 Vegfr3 inhibitors
02/20/2014US20140051854 Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
02/20/2014US20140051762 Polycationic compounds and uses thereof
02/20/2014US20140051715 3,5 Phenyl-Substituted Beta Amino Acid Derivatives as Integrin Antagonists
02/20/2014US20140051712 Blood brain barrier-penetrating oximes for cholistenerases reactivation
02/20/2014US20140051703 Thiopyrimidine-based compounds and uses thereof
02/20/2014US20140051674 New compounds
02/20/2014US20140051611 Crosslinking Composition for Hydrocarbon Gels
02/19/2014EP2697347A1 Equilibrated dynamic mixtures to control the release of perfuming aldehydes and ketones
02/19/2014EP2697206A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 427